Related Experiment Video
Updated: Aug 29, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Therapy of advanced non-small-cell lung cancer with irinotecan and gemcitabine in combination
Juliana Ribeiro de Freitas1, Caio M Rocha-Lima
1Universidade Federal da Bahia, Salvador, Bahia, Brazil.
Abstract:
Non-small-cell lung cancer is the leading cause of cancer-related deaths in the United States. Chemotherapy has been shown to improve survival and quality of life in patients with advanced disease when compared to best supportive care. Of the commonly used therapies, platinum in combination with gemcitabine, taxanes, and vinorelbine offers superior activity to single-agent platinum or older platinum combinations. In addition, single-agent gemcitabine or single-agent paclitaxel has resulted in lower survival compared to each in combination with carboplatin in 2 recently reported phase III trials. However, among themselves new doublets have shown no improvement in survival, and treatment has traditionally been chosen based on convenience and toxicity rather than efficacy. The combination of gemcitabine and irinotecan has demonstrated promising results in preclinical studies. In this review, the data available on the combination of gemcitabine and irinotecan in phase I and phase II trials are discussed.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers

